The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections.
about
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportH pylori antibiotic resistance: prevalence, importance, and advances in testingSecond and third line treatment options for Helicobacter pylori eradicationThe diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert CommentaryReinfection after successful eradication of Helicobacter pylori in three different populations in Alaska.The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin AmericaDiagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population.International Circumpolar Surveillance, an Arctic network for the surveillance of infectious diseasesHelicobacter pylori in patients can be killed by visible light.Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial.Facing resistance of H.pylori infectionHelicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sectionsRescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycinAmerican College of Gastroenterology guideline on the management of Helicobacter pylori infection.Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium.Characterization of Helicobacter pylori cagA and vacA genotypes among Alaskans and their correlation with clinical disease.Alaska sentinel surveillance study of Helicobacter pylori isolates from Alaska Native persons from 2000 to 2008A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pyloriEfficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe.Therapy of Helicobacter pylori.Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study.Management issues in dyspepsia: current consensus and controversies.A review of the microbiology, antibiotic usage and resistance in chronic skin wounds.The effect of Helicobacter pylori infection on iron stores and iron deficiency in urban Alaska Native adultsMutations in Helicobacter pylori porD and oorD genes may contribute to furazolidone resistanceEradication of Helicobacter pylori: recent advances in treatment.Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005.Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria.Influence of pretreatment with H2 receptor antagonists on the cure rates of Helicobacter pylori eradication.Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice.Helicobacter pylori infection in Canadian and related Arctic Aboriginal populations.Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.Review article: the global emergence of Helicobacter pylori antibiotic resistance.In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori.Adherence and barriers to H. pylori treatment in Arctic Canada.
P2860
Q24674636-8D18792D-BA77-4F48-9D72-B69891D8557DQ24685864-5791A5F5-A3D6-48AB-96DA-DFB6557F55C9Q26829666-57BE8EAE-596E-4808-9114-F3492C0A3C76Q26852409-A3D3E214-7494-4B71-8041-3C8E4A5DDCA9Q30209223-EEFAC404-1BD7-4EBB-9010-BAD0982FEF85Q30217199-CF2FA021-78DE-4F48-9045-F6A1D237F8FDQ30224839-154D2FD2-942C-4DEB-A3F3-85B6B3AFEB12Q30229114-11C6D2B7-6A08-4132-BE8D-703797B2FC85Q31156292-79BC7691-192A-4B21-8B77-7E34352C0EB4Q33469754-099108A3-61C1-47D1-AD6F-7D8E22938C1EQ33596218-5730F1A6-0A6F-45C9-BE80-292271914B08Q33810991-F7200C08-1929-449C-A39C-0FF04C243964Q33884860-2348354D-5D15-4123-A8DB-447525B58B78Q33916743-DC2753F8-539B-4E1A-9CFD-72B91486463CQ34604699-9A53EEB7-DB1F-4E8D-ACE2-40CF70230D71Q34645482-34301A8D-9CA5-4B2D-BBB1-B86FA725B44FQ35066862-085AC89F-632E-4845-B667-3E4B0BE53C85Q35192162-6E7F4626-F1EF-4619-8393-003079A29C42Q35273580-D690F911-812C-44AC-BEA4-FB5C034710CDQ35532235-B2ABF920-A403-4025-A9F8-C85A2A507A7FQ35534113-AAC4D98F-A692-4391-A580-D0E9AB5DF9B5Q35594239-71BBEB48-6B29-4A2A-A7B8-40B06DAFAAC6Q35760968-004CCD96-BBD2-475B-B080-183F0695FDE3Q35878337-E428EA51-3796-4CD3-B708-8E476C3472D4Q35896413-216CEFD6-8476-42C7-9FD8-33E02B33302FQ35932402-988C2C7F-575D-43AF-B643-4AA43CF71E7EQ36009107-415446E2-2EFA-412A-B5D4-17C6E3152D42Q36045719-87DF3957-4200-4249-8F2B-9BFAFA310940Q36147666-75B255FB-D55A-42ED-AE1A-77771EC9C181Q36191284-F70B0A65-A02B-4492-AF53-F436E567956DQ36314577-298C9FD5-D202-409E-9E09-C043D63FF58BQ36423165-E30AE3C7-A07A-4151-AC68-168D741D7D6DQ36500730-C8C817F8-CEAE-469A-A914-B3896E742D67Q36516636-D075597B-E4F9-43A1-BBD2-4D532DAB8378Q36997005-ED33B806-222E-44F6-AA59-46665358E94FQ37114662-906759EC-2954-4795-A35A-C1A3BA66CC5EQ37333166-7A45AE4E-2BA9-49CD-B1C7-C79D8158F96CQ37340339-6B46DC6B-F50E-430A-94C6-09939FA0BF75Q37392936-815080DF-8125-4CCD-B297-390C49B5B167Q37459957-3E7D4391-EBFE-47A2-BD31-0305019D22B3
P2860
The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The relationship among previou ...... elicobacter pylori infections.
@en
The relationship among previou ...... elicobacter pylori infections.
@nl
type
label
The relationship among previou ...... elicobacter pylori infections.
@en
The relationship among previou ...... elicobacter pylori infections.
@nl
prefLabel
The relationship among previou ...... elicobacter pylori infections.
@en
The relationship among previou ...... elicobacter pylori infections.
@nl
P2093
P1476
The relationship among previou ...... elicobacter pylori infections.
@en
P2093
Alan J Parkinson
Alisa L Reasonover
Brian J McMahon
Debby A Hurlburt
Frank Sacco
J Michael Bensler
Jay C Butler
Julie M Morris
Michael G Bruce
P304
P356
10.7326/0003-4819-139-6-200309160-00008
P407
P577
2003-09-01T00:00:00Z